NCT04660929 2024-12-18CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsCarisma Therapeutics IncPhase 1 Active not recruiting48 enrolled
NCT03184558 2021-11-09Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBCBerGenBio ASAPhase 2 Terminated29 enrolled 10 charts
NCT00105950 2015-09-28Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast CancerGlaxoSmithKlinePhase 2 Completed126 enrolled
NCT00558103 2013-02-04Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast CancerGlaxoSmithKlinePhase 2 Completed163 enrolled 14 charts
NCT00891280 2011-06-15Dose-escalation Study of Oral CX-4945Cylene PharmaceuticalsPhase 1 Unknown55 enrolled